Nimbus Announces Change to Business Board
Complete the form below to unlock access to ALL audio articles.
Nimbus Biotechnology has reported a change to the company’s Supervisory Board. Professor Axel Kleemann, formerly executive board member of Asta Medica AG has been appointed as a new member and chairman of the Supervisory Board.
Professor Thomas Bayerl, Dr. Rainer Strohmenger (Wellington Partners Venture Capital GmbH, Germany), Jack Griffin and Mario Ober (CFH, Germany) continue to be board members.
Nimbus Biotechnology thanks Werner Zollner (Seed GmbH, Germany) for his former work and support in this position.
Wolfgang Lerch, CEO of Nimbus Biotechnology, stated, "The appointment of Professor Axel Kleemann is a very special opportunity for Nimbus Biotechnology."
"With his expertise we will strengthen our mission to support our customers with cutting-edge tools."
"We will come closer to developing modern tools for all stages of drug discovery. All employees of the company wish him success for his work."
